Primary tabs

Export products to Excel

Displaying 151 - 165 of 213
Product Alternative Name Development Status Target Mode Active Pharmaceutical Ingredient (API) Delivery Type Duration Type Project Stage Partner Updated date
PETOGEN 150 mg/mL Injection Limited Market Approval Female Hormonal medroxyprogesterone acetate Injectable Long-acting Marketed Helm Pharmaceuticals, Fresenius Kabi 05/30/2018
Phoenurse Female Condom SRA/WHO PQ Approved Female Non-hormonal Barrier Pericoital Marketed Tianjin Condombao Medical Polyurethane Tech. Co. Ltd 07/22/2016
PLA/PLGA Injectable Microspheres Active Development Female Hormonal levonorgestrel Injectable Long-acting Pre-clinical Shanghai Institute of Planned Parenthood Research (SIPPR), FHI 360 05/30/2018
PLGA Microspheres Encapsulating LNG and EE Female Hormonal levonorgestrel, ethinyl estradiol Injectable Pre-clinical Vel's College of Pharmacy 05/30/2018
Polidocanol Polidocanol Foam Permanent Contraception Active Development Female Non-hormonal polidocanol Fallopian Tube Permanent Pre-clinical Oregon Health & Science University 05/30/2018
Polymer Coated Copper IUD Active Development Female Non-hormonal copper Intrauterine Long-acting Phase II HLL Lifecare Limited 05/30/2018
Polymersomes Vaginal Gel Inactive Female Hormonal Vaginal Gel Pericoital Target ID/Validation Vindico NanoBio Technology Inc. 07/30/2016
Praneem tablet Inactive Female Non-hormonal Vaginal, Other Short-acting Phase II Indian Council for Medical Research, Talwar Research Foundation 05/30/2018
Pregna Postpartum IUD Active Development Female Non-hormonal copper Intrauterine Long-acting Regulatory Pregna International Limited 05/30/2018
Progering Progesterone Vaginal Ring (PVR) Limited Market Approval Female Hormonal progesterone Vaginal Ring Long-acting Regulatory Population Council, Grunenthal 05/30/2018
Progestin-Only Cream “Mini-pill” cream Active Development Female Hormonal progestin Transdermal Short-acting Pre-clinical Viramal Limited 07/26/2016
Prostaglandin E2 Receptor Antagonists Prostaglandin E2 (PGE2) Synthesis / Signaling inhibitors Active Development Female Non-hormonal Prostaglandin E2 Receptor Antagonist TBD TBD Target ID/Validation Oregon Health & Science University, Bayer HealthCare 07/26/2016
Quinacrine Pellets Quinacrine Sterilization (QS) Inactive Female Non-hormonal quinacrine hydrochloride Intrauterine Permanent Phase III ISAF 07/26/2016
RAR antagonists Retinoic acid receptor (RAR) antagonists Active Development Male Non-hormonal Short-acting Target ID/Validation NICHD, Columbia University, University of Washington, University of Minnesota 05/30/2018
Reddy Latex Female Condom VA w.o.w. SRA/WHO PQ Approved Female Non-hormonal Barrier Pericoital Marketed HLL Lifecare Limited 05/30/2018
Export to Excel